fda glp-1 enforcement news issued 30 warning letters to telehealth companies for false and misleading claims about compounded products. This marks the second round of action since the agency's September crackdown on misleading GLP-1s in 2026: What Brokers

10.1002/mbo3.612 [DOI] [PMC free article] [PubMed] [Google Scholar] 47.Jiang XE, Yang SM, Zhou XJ, Zhang Y

Under Section 503A, a drug may be compounded for an identified individual patient based on a valid prescription

Injection supplies including syringes and alcohol swabs come included, along with clear dosing and injection instructions

The organization asked the FDA to work with federal partners to stop the flow of counterfeit drugs entering the U.S

A Nature-published study using molecular modelling and receptor-binding studies provided structural insights into retatrutide's simultaneous agonism at GLP-1R, GIPR, and GCGR, confirming that retatrutide binds all three as a single molecule without losing potency at any individual receptor

Clean and Clinically Studied: HUM products are Clean Label Project Certified, non-GMO, and carefully formulated to meet consistent standards for safety and quality